TSP Advanced Technologies Plc, a medical device company, engages in the development of spinal stabilization products in the United Kingdom and the United States. It offers Cervi-LOK, a screw free spinal stabilization system for cervical and upper thoracic spine; Faci-LOK, a system for lumbar and lower thoracic vertebra; and GRASP Laminoplasty system, a treatment for decompression of the spinal cord. The company was formerly known as TruSpine Technologies Plc and changed its name to TSP Advanced Technologies Plc in November 2025. TSP Advanced Technologies Plc was incorporated in 2014 and is based in London, the United Kingdom.
Metrics to compare | TSP | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipTSPPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.3x | −1.1x | −0.6x | |
PEG Ratio | 0.32 | 0.07 | 0.00 | |
Price/Book | 0.4x | 1.4x | 2.6x | |
Price / LTM Sales | - | 2.4x | 3.4x | |
Upside (Analyst Target) | - | 119.9% | 42.5% | |
Fair Value Upside | Unlock | 18.9% | 5.8% | Unlock |